Johnson & Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year—and 3.5% after discounts—in the health-products company’s first effort to address criticism about the high cost of medicines by opening up about its drug-pricing practices.
from WSJ.com: US Business http://ift.tt/2lZCBkQ
via IFTTT
No comments:
Post a Comment